Photo from Marlise R. Luskin/X
Oct 1, 2024, 11:39
Marlise R. Luskin: Severe neutropenia is associated with blinatumomab
Marlise R. Luskin, leukemia specialist at Dana-Farber Cancer Institute, posted on X:
“Severe neutropenia is associated with blinatumomab! Blina is not considered myelosuppressive, but have observed severe neutropenia. We studied 95 pts receiving blina in CR at Dana-Farber Cancer Institute 41% gr≥3 neutropenia, 13% ANC <100, no serious infections, not necessarily recurrent!”
Source: Marlise R. Luskin/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20